Aclarubicin stimulates RNA polymerase II elongation at closely spaced divergent promoters
Science Advances · 16.06.2023 · 9 (24)
DOI: 10.1126/sciadv.adg3257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 16.06.2023. Verfasst von Matthew Wooten und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fred Hutchinson Cancer Center, Seattle, WA 98109, USA. Hauptthemen laut MEDLINE: Aclarubicin, Polyketides. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS.
Abstract (Originalsprache)
Anthracyclines are a class of widely prescribed anticancer drugs that disrupt chromatin by intercalating into DNA and enhancing nucleosome turnover. To understand the molecular consequences of anthracycline-mediated chromatin disruption, we used Cleavage Under Targets and Tagmentation (CUT&Tag) to profile RNA polymerase II during anthracycline treatment in Drosophila cells. We observed that treatment with the anthracycline aclarubicin leads to elevated levels of RNA polymerase II and changes in chromatin accessibility. We found that promoter proximity and orientation affect chromatin changes during aclarubicin treatment, as closely spaced divergent promoter pairs show greater chromatin changes when compared to codirectionally oriented tandem promoters. We also found that aclarubicin treatment changes the distribution of noncanonical DNA G-quadruplex structures both at promoters and at G-rich pericentromeric repeats. Our work suggests that the cancer-killing activity of aclarubicin is driven by the disruption of nucleosomes and RNA polymerase II.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
- Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
ORCID-Profile: Matthew Wooten, Kami Ahmad, Steven Henikoff
Förderung
- NHGRI NIH HHS
Zitieren
APA
Wooten, M., Takushi, B., Ahmad, K., & Henikoff, S. (2023). Aclarubicin stimulates RNA polymerase II elongation at closely spaced divergent promoters. Science Advances, 9(24). https://doi.org/10.1126/sciadv.adg3257
Vancouver
Wooten M, Takushi B, Ahmad K, Henikoff S. Aclarubicin stimulates RNA polymerase II elongation at closely spaced divergent promoters. Science Advances. 2023;9(24). doi:10.1126/sciadv.adg3257
BibTeX
@article{Wooten2023,
author = {Wooten, Matthew and Takushi, Brittany and Ahmad, Kami and Henikoff, Steven},
title = {Aclarubicin stimulates RNA polymerase II elongation at closely spaced divergent promoters},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {24},
doi = {10.1126/sciadv.adg3257}
}
EUVIMED